Nomura Asset Management
ROIV icon

Nomura Asset Management’s Roivant Sciences ROIV Stock Holding History

Nomura Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Buy
+820
New +$24.2K ﹤0.01% 1186
2026
Q1 		– Sell
-2,200
Closed -$56.5K – 1584
2025
Q4 		$47.7K Hold
2,200
– – ﹤0.01% 1156
2025
Q3 		$33.3K Hold
2,200
– – ﹤0.01% 1279
2025
Q2 		$24.8K Hold
2,200
– – ﹤0.01% 1356
2025
Q1 		$22.2K Buy
+2,200
New +$23.8K ﹤0.01% 1392

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Nomura Asset Management's ROIV Position: Q2 2026 in Review

Nomura Asset Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 820 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #1186 among its holdings. This is a return to the name: Nomura Asset Management previously reported a position in ROIV as recently as Q4 2025.

Nomura Asset Management first reported a position in ROIV in Q1 2025 and has held it in 5 quarters since. The position peaked at $47.7K in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Nomura Asset Management held 820 shares of Roivant Sciences worth $29K as of Q2 2026.
  • Roivant Sciences was a new Nomura Asset Management position in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #1186 holding.
  • Nomura Asset Management first reported a position in Roivant Sciences in Q1 2025 and has held it in 5 quarters since.
  • Nomura Asset Management's Roivant Sciences position peaked at $47.7K in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.